These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12440819)

  • 1. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
    Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N
    Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
    Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB
    Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
    Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
    J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
    Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
    Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.
    Lim KH; Telisinghe PU; Abdullah MS; Ramasamy R
    Cancer Immun; 2010 Jan; 10():3. PubMed ID: 20092246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
    Nurlaila I; Telisinghe PU; Ramasamy R
    Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.
    Kuroda H; Tamaru J; Sakamoto G; Ohnisi K; Itoyama S
    Virchows Arch; 2005 Jan; 446(1):10-4. PubMed ID: 15660281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate.
    Kleer CG; Michael CW
    Diagn Cytopathol; 2000 Jul; 23(1):39-42. PubMed ID: 10907931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast.
    Guo X; Fan Y; Lang R; Gu F; Chen L; Cui L; Pringle GA; Zhang X; Fu L
    Mod Pathol; 2008 Sep; 21(9):1101-7. PubMed ID: 18469794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
    Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
    Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
    Gaffey MJ; Frierson HF; Mills SE; Boyd JC; Zarbo RJ; Simpson JF; Gross LK; Weiss LM
    Mod Pathol; 1993 Nov; 6(6):721-8. PubMed ID: 8302815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
    Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
    Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.
    Yajima R; Yajima T; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Tsutsumi S; Iijima M; Kuwano H
    Breast Cancer; 2016 Jul; 23(4):668-74. PubMed ID: 26071015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.
    Brown JR; Wimberly H; Lannin DR; Nixon C; Rimm DL; Bossuyt V
    Clin Cancer Res; 2014 Dec; 20(23):5995-6005. PubMed ID: 25255793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type.
    Zhao Y; Huang T; Jin X; Gong XM; Lu YZ
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):354-362. PubMed ID: 37278279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.
    Verma R; Hanby AM; Horgan K; Verghese ET; Volpato M; Carter CR; Hughes TA
    Breast Cancer Res Treat; 2020 Aug; 183(1):49-59. PubMed ID: 32577938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype.
    Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A
    Ann Oncol; 2005 Jul; 16(7):1094-9. PubMed ID: 15855225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.